使用CRISPR/Cas9技术构建DNMT3A R882H细胞系用于质控急性髓系白血病分子检测
王宁, 魏亚丽, 安旭, 曹沁梅, 周睿
A Novel DNMT3A R882H Cell Line Generated Using CRISPR/Cas9 Technology as a Universal Quality Control Material for Clinical Testing in Acute Myeloid Leukemia
WANG Ning,WEI Ya-Li,AN Xu,CAO Qin-Mei,ZHOU Rui
中国生物化学与分子生物学报
.
2021, (8): 1118
-1123
.
DOI: 10.13865/j.cnki.cjbmb.2021.07.1228
